The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
基本信息
- 批准号:7837633
- 负责人:
- 金额:$ 7.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-11 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AlveolarAnti-Inflammatory AgentsAnti-inflammatoryAntioxidantsApoptosisApoptoticBiochemical PathwayBiologicalCalnexinCell DeathCellsChronicChronic Obstructive Airway DiseaseCigaretteCigarette SmokerDataDevelopmentDiseaseEndoplasmic ReticulumEpithelial CellsErythroidFibrosisGRP78 geneGene ExpressionGoldHarvestHomeostasisHumanIn SituIn VitroIndividualLasersLectinLungLung InflammationLung diseasesMetaplasiaMicroscopyMolecular ChaperonesNF-E2-related factor 2NuclearOxidantsPathogenesisPhosphotransferasesPredispositionProtein Disulfide IsomeraseProteinsPulmonary EmphysemaResearchRisk FactorsSignal PathwaySignal TransductionSmokeSmokerStagingStreamStructure of parenchyma of lungTechniquesTestingTissue SampleTissuesUp-RegulationWorkabstractingactivating transcription factor 4basecalreticulincell typecigarette smoke-inducedcigarette smokingcigarette smokingcommon cellular transcription factor ATFendoplasmic reticulum stressimprovednoveloxidant stresspreventprotein kinase Rpublic health relevanceresponsetranscription factortranscription factor CHOP
项目摘要
DESCRIPTION (provided by applicant):
Cigarette smoking induced chronic obstructive pulmonary disease (COPD) is characterized by alveolar epithelial cell death and airway metaplasia and fibrosis. We have shown that the lungs of chronic cigarette smokers without COPD manifest a compensatory response to endoplasmic reticulum stress termed the unfolded protein response (UPR) and that the UPR-related transcription factors, ATF-4 and Nrf2, proteins which regulate anti-oxidant gene expression, are up-regulated by CS in cultured airway epithelial cells. These data raise the possibility that the UPR protects lung cells against oxidant stress and the development of COPD. However, when ER stress is sufficiently severe and protein homeostasis cannot be restored, the UPR causes apoptosis by up-regulating expression of the pro-apoptotic transcription factor, CHOP. These latter observations raise the alternative possibility that the UPR may contribute to the pathogenesis of emphysema by inducing cell apoptosis. Our previous studies were performed in whole lung lysates and cultured airway epithelial cells. We have not studied the in situ response of specific lung cell types to cigarette smoke exposure. Accordingly, the specific Aim of this 2 year project is to characterize the UPR induced by cigarette smoke in a lung cell involved in the pathogenesis of COPD, i.e., airway epithelial cells. We will test the hypotheses that UPR response to cigarette smoke is impaired in the airway epithelial cells of subjects with COPD. Expression of the UPR hallmark proteins (i.e., GRP78, calreticulin, calnexin and protein disulfide isomerase), oxidant defense (i.e., Nrf2 and ATF4) and apoptosis (i.e., CHOP) will be compared in airway epithelial cells from subjects with and without COPD. Cells will be harvested from ex-- smokers without COPD (n=10) and ex-smokers with COPD in GOLD stages II (n=10) and IV (n=10) using the technique of laser capture microscopy applied to HOPE fixed, inflated lung tissue sections. A better understanding of the cellular basis of the UPR induced by CS should enhance our understanding of the pathogenesis of COPD. PUBLIC HEALTH RELEVANCE: Cigarette smoking is a risk factor for chronic obstructive pulmonary disease (COPD), a disease characterized by inflammation, and lung cell death. However, the pathogenesis of this disease remains incompletely understood and current therapies are inadequate. Our recent work shows that a novel biochemical pathway induced in the lung by cigarette smoking can be protective. This response and its biological consequences will be studied in cell type known to be involved with COPD. The results obtained are expected to improve our understanding of cigarette smoke-related lung disease and contribute to the development of new and better treatments. (End of Abstract)
描述(由申请人提供):
吸烟引起的慢性阻塞性肺疾病(COPD)的特征是肺泡上皮细胞死亡和气道变质和纤维化。 We have shown that the lungs of chronic cigarette smokers without COPD manifest a compensatory response to endoplasmic reticulum stress termed the unfolded protein response (UPR) and that the UPR-related transcription factors, ATF-4 and Nrf2, proteins which regulate anti-oxidant gene expression, are up-regulated by CS in cultured airway epithelial cells.这些数据增加了UPR保护肺细胞免受氧化应激和COPD发展的可能性。但是,当ER应激足够严重并且无法恢复蛋白质稳态时,UPR通过上调促凋亡转录因子的表达而引起凋亡。这些后一种观察结果提出了一种替代可能性,即UPR可能通过诱导细胞凋亡来促进肺气肿的发病机理。我们先前的研究是在整个肺裂解物和培养的气道上皮细胞中进行的。我们尚未研究特定的肺细胞类型对香烟烟雾暴露的原位反应。因此,该2年项目的具体目的是表征与COPD发病机理(即气道上皮细胞)中的肺部烟雾引起的UPR。我们将测试以COPD受试者的气道上皮细胞中UPR对香烟烟雾的反应的假设。 UPR Hallmark蛋白(即GRP78,钙网蛋白,钙网蛋白和蛋白质二硫化物异构酶),氧化剂防御(即NRF2和ATF4)和凋亡(即CHOP)的表达将在患有和没有COPD的受试者的受试者中进行比较。使用激光捕获显微镜的技术,将从没有COPD的EX-吸烟者(n = 10)和具有COPD的Ex-Smoker中收集细胞,并使用激光捕获显微镜的技术来收获细胞。对CS诱导的UPR的细胞基础的更好理解应增强我们对COPD发病机理的理解。 公共卫生相关性:吸烟是慢性阻塞性肺疾病(COPD)的危险因素,该疾病是炎症和肺部细胞死亡的特征。然而,该疾病的发病机理仍未完全理解,目前的疗法不足。我们最近的工作表明,通过吸烟在肺部引起的一种新型的生化途径可以保护。该反应及其生物学后果将在已知与COPD有关的细胞类型中进行研究。预计获得的结果将提高我们对香烟烟有关的肺部疾病的理解,并有助于新的和更好的治疗方法的发展。 (抽象的结尾)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SALIM MERALI其他文献
SALIM MERALI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SALIM MERALI', 18)}}的其他基金
Adipose Tissue Carbonylome and Sustained Calorie Restriction
脂肪组织羰基化和持续热量限制
- 批准号:
9807394 - 财政年份:2019
- 资助金额:
$ 7.5万 - 项目类别:
Activators of Nrf2 Translation in Alzheimer's Disease
阿尔茨海默病中 Nrf2 翻译的激活剂
- 批准号:
9267399 - 财政年份:2016
- 资助金额:
$ 7.5万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8525356 - 财政年份:2012
- 资助金额:
$ 7.5万 - 项目类别:
Detection of Novel Polyamine Analogs with Anti-Prostate Cancer Activity
具有抗前列腺癌活性的新型多胺类似物的检测
- 批准号:
8385709 - 财政年份:2012
- 资助金额:
$ 7.5万 - 项目类别:
The Unfolded Protein Response in Human Airway and Alveolar Epithelial Cells
人类气道和肺泡上皮细胞中未折叠的蛋白质反应
- 批准号:
7713872 - 财政年份:2009
- 资助金额:
$ 7.5万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7122212 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7532766 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7322500 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
7151923 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
S-Adenosylmethionine and Pneumocystis treatment
S-腺苷甲硫氨酸和肺孢子虫治疗
- 批准号:
6893248 - 财政年份:2004
- 资助金额:
$ 7.5万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:82204218
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:82103973
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Translational Multimodal Strategy for Peri-Implant Disease Prevention
种植体周围疾病预防的转化多模式策略
- 批准号:
10736860 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Investigating the Contribution of the Coxiella Cell Wall to Intracellular Pathogenesis
研究柯克斯体细胞壁对细胞内发病机制的贡献
- 批准号:
10593290 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别:
Mechanisms of peroxisome proliferator-activated receptor-alpha regulation in peridontitis
过氧化物酶体增殖物激活受体-α在牙周炎中的调节机制
- 批准号:
10915090 - 财政年份:2023
- 资助金额:
$ 7.5万 - 项目类别: